Persistent androgen receptor addiction in castration-resistant prostate cancer - Wikidata - wikimedia - TriplyDB

Persistent androgen receptor addiction in castration-resistant prostate cancer

Persistent androgen receptor addiction in castration-resistant prostate cancer

http://www.wikidata.org/entity/Q26777163

about

Targeting intratumoral androgens: statins and beyond AR-Signaling in Human Malignancies: Prostate Cancer and Beyond.Androgen Receptor Regulates the Growth of Neuroblastoma Cells in vitro and in vivo Targeting persistent androgen receptor signaling in castration-resistant prostate cancer.mTOR Inhibitors in Castration-Resistant Prostate Cancer: A Systematic Review.Global analysis of transcription in castration-resistant prostate cancer cells uncovers active enhancers and direct androgen receptor targets.Prostate-specific IL-6 transgene autonomously induce prostate neoplasm through amplifying inflammation in the prostate and peri-prostatic adipose tissue.Targeting constitutively active androgen receptor splice variants in castration resistant prostate cancer A comprehensive data mining study shows that most nuclear receptors act as newly proposed homeostasis-associated molecular pattern receptors.Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity.A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer.

P2860

Q28073619-CA5F0E3F-60FE-4DCE-90C7-FB239CC1B91C Q37629545-31480DAC-9293-4AB4-97B2-8ED16494B954 Q37683259-31A959FC-FB6E-4A7D-A331-2A595CBC671A Q38797560-108E59F1-7C59-4B2D-9BBB-DF5D107CC49B Q38922287-270C0A47-5A90-47BC-B808-695E02B6A248 Q39376859-4C6476EB-68A0-4AA3-9A05-D400B3054123 Q41204113-9B990DEE-5A25-4726-81EE-3985CB05F6BD Q42182625-6D1A6861-8906-4F54-A71A-760DAABFA26F Q42634180-1A9E8DC5-7D24-4A66-B37E-6F1B4D89E168 Q52319664-09BFAB08-E3ED-4BAB-BA94-BFEA270E11E5 Q55208854-573A9324-DF58-4630-9856-B1BC2B13BBCF

P2860

Persistent androgen receptor addiction in castration-resistant prostate cancer

http://www.wikidata.org/entity/Q26777163

description

2015 nî lūn-bûn

@nan

2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Persistent androgen receptor addiction in castration-resistant prostate cancer

@ast

Persistent androgen receptor addiction in castration-resistant prostate cancer

@en

Persistent androgen receptor addiction in castration-resistant prostate cancer

@nl

type

label

Persistent androgen receptor addiction in castration-resistant prostate cancer

@ast

Persistent androgen receptor addiction in castration-resistant prostate cancer

@en

Persistent androgen receptor addiction in castration-resistant prostate cancer

@nl

prefLabel

Persistent androgen receptor addiction in castration-resistant prostate cancer

@ast

Persistent androgen receptor addiction in castration-resistant prostate cancer

@en

Persistent androgen receptor addiction in castration-resistant prostate cancer

@nl

P1433

Q26777163-C43B189A-CC1E-4E6C-82AC-1FC7848332C8

P1476

Q26777163-13B8BBCA-477C-4A6F-957E-47C591815BB3

P2093

Q26777163-12C501D5-F2B3-4950-A0A3-45A89468B1FE

Q26777163-79B2F531-CFA7-45E7-A617-FB0FE6893C77

P275

Q26777163-B98F1585-CC25-4791-8643-E59AF071077B

P2860

Q26777163-00AB2D34-E4A3-4F86-BFC5-370459596500

Q26777163-01F122D5-BB2D-4411-9379-5D01BC2AA06B

Q26777163-02313E2B-6EB7-46A5-BCFC-EC4EF81351A8

Q26777163-03C67BCD-6CEF-480B-B334-F132506E4975

Q26777163-03E08EFC-CA50-40FB-B442-BB3AC3153FE0

Q26777163-07147588-2C3D-4AC7-93B7-77144B84B2F2

Q26777163-0991E26C-6E9D-4FA6-9485-7431B0F794FC

Q26777163-10BC7AE3-F7AB-405F-A1E3-208A264FEEAB

Q26777163-13D06FFE-D5D5-4452-BAAF-1A02B923B567

Q26777163-1417132C-A97F-4D8E-ACFB-7A6893A558EE

P2888

Q26777163-B324D435-A908-4255-BD33-AE037A22FAE2

P304

Q26777163-AB2F9DBB-9BB6-4748-9970-DFDCFA28CE90

P31

Q26777163-3B6E1059-9F15-4A18-AEA1-E06E820A2A64

Q26777163-4A1E5DA5-7006-4EFB-9518-836D88C701BB

P3181

Q26777163-F6E5FF0C-B88B-47E4-9D5E-C8498C3F8A6D

P356

Q26777163-D098E6E0-0D27-4BEB-A3D3-56A0F6FFA914

P407

Q26777163-BE7F3E5E-0564-402A-9223-30C474CEC01A

P433

Q26777163-28FA708A-ED5D-4A86-B102-21C8B104B072

P478

Q26777163-E26BB16C-09BB-4EBD-8878-15E92317B488

P5008

Q26777163-72D7DB45-ECE5-422C-A56A-25923430C9E4

P577

Q26777163-CE031E58-F5D0-4EA3-9A5D-0810D98898EF

P5875

Q26777163-8F91D30E-2938-433B-9EC6-2296E54351FA

P6179

Q26777163-0D1461D7-6FF2-44AD-B06A-1D8F5ED1E1B3

P698

Q26777163-ADCCC3BB-5878-41B9-94C7-5C45E9D8ACCD

P921

Q26777163-05193C27-5823-48CA-B7B6-E61926C2C4F7

Q26777163-71FCC978-79C7-4064-8075-EA2D52E4F327

Q26777163-90E6110E-F884-4A11-B0E4-C5CA4F320A64

Q26777163-D7C29E3C-A76E-422D-8827-4B278DE871E9

Q26777163-DF090878-6883-4BF7-B431-E8F01F623FE0

P932

Q26777163-C20C1186-51F2-4177-94BE-C3BEA752C43A

P3181

P356

S13045-015-0225-2

P1433

Journal of Hematology & Oncology

P1476

Persistent androgen receptor addiction in castration-resistant prostate cancer

@en

P2093

Evan Y Yu

http://www.w3.org/2001/XMLSchema#string

Michael T Schweizer

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Beta-catenin affects androgen receptor transcriptional activity and ligand specificity

Abiraterone in metastatic prostate cancer without previous chemotherapy

Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor

The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations

Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in caucasian patients with androgen-independent prostatic cancer

From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells

Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study.

Development of Potent and Selective Indomethacin Analogues for the Inhibition of AKR1C3 (Type 5 17β-Hydroxysteroid Dehydrogenase/Prostaglandin F Synthase) in Castrate-Resistant Prostate Cancer

Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.

Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08).

P2888

s13045-015-0225-2

P304

128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3472859

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/S13045-015-0225-2

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2015-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283853962

http://www.w3.org/2001/XMLSchema#string

P6179

1020475230

http://www.w3.org/2001/XMLSchema#string

P698

26566796

http://www.w3.org/2001/XMLSchema#string

P921

intracellular receptor

hormone antagonist

heterocyclic compound

polycyclic compound

castration-resistant prostatic neoplasm

P932

4644296

http://www.w3.org/2001/XMLSchema#string